1-11 of 11
Emmanuel Raffoux, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hyper-CVAD Plus Epratuzumab As Salvage Regimen for Younger Relapsed/Refractory CD22+ B Acute Lymphoblastic Leukemia (ALL) Patients: Results of the Phase 2 Prospective Cheprall Study

Patrice Chevallier, MD PhD, Sylvain Chantepie, MD, Françoise Huguet, MD, Emmanuel Raffoux, MD PhD, Xavier Thomas, MD PhD, Thibaut Leguay, MD, Tony Marchand, MD, Francoise Isnard, MD PhD, Aude Charbonnier, Sebastien Maury, MD PhD, Maria-Pilar Gallego-Hernanz, MD, Nelly Robillard, PhD, Thierry Guillaume, MD PhD, Pierre Peterlin, MD, Alice Garnier, MD, Fanny Rialland, MD, Claire Le Houerou, David M Goldenberg, ScD, MD, William Wegener, MD PhD, Marie C Bene, Pharm SciD, PhD, Herve Dombret, MD
Journal: Blood
Blood (2016) 128 (22): 4018.
https://doi.org/10.1182/blood.V128.22.4018.4018
Published: 2016
Journal Articles

Evidence of Differentiation in Myeloid Malignancies Associated Neutrophilic Dermatosis

Pierre Sujobert, Wendy Cuccuini, Herve Dombret, Marie-Dominique Vignon-Pennamen, Emmanuel Raffoux, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2566.
https://doi.org/10.1182/blood.V118.21.2566.2566
Published: 2011
Journal Articles

Single-Agent Dasatinib Does Not Prevent Hematological Relapse in Patients with Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) in First Complete Remission, but Persistent or Re-Appearing Molecular Minimal Residual Disease–Results of the DASA-CBF Trial From the French AML Intergroup

Nicolas Boissel, Eric Jourdan, Arnaud Pigneux, MD, PhD, Odile Blanchet, Aline Renneville, Christian Recher, MD, PhD, Emmanuel Raffoux, MD, PhD, Pascale Cornillet-Lefebvre, Jean-Michel Cayuela, Jacques Delaunay, Eric Delabesse, Claude-Eric Bulabois, Céline Berthon, Cécile Pautas, Norbert Vey, MD, Bruno Lioure, Xavier Thomas, Leila Kammoun, MD, Edouard Randriamalala, Nathalie Fegueux, Thibaud Lecerf, Marie-Christine Béné, Claude Preudhomme, Hesham Mohamed, Hervé Dombret, Norbert Ifrah
Journal: Blood
Blood (2011) 118 (21): 2608.
https://doi.org/10.1182/blood.V118.21.2608.2608
Published: 2011
Journal Articles

Use of Clofarabine in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Adults: The French Experience

David Sibon, MD, PhD, Ana Berceanu, MD, David Ghez, MD, PhD, Frantz Foissac, Leila Kammoun, MD, Thorsten Braun, MD, Denis Caillot, MD, Mario Ojeda-Uribe, MD, Romain Guieze, MD, Céline Berthon, MD, Laurence Sanhes, MD, Bérengère Gruson, MD, Didier Bouscary, MD, PhD, Christian Recher, MD, PhD, Laure Stalnikiewicz, MD, Philippe Rousselot, MD, PhD, Emmanuel Raffoux, MD, PhD, Thomas Prebet, MD, PhD, Bruno Salles, MD, Stéphane de Botton, MD, PhD, Ambroise Marcais, MD, Felipe Suarez, MD, PhD, Olivier Hermine, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2623.
https://doi.org/10.1182/blood.V118.21.2623.2623
Published: 2011
Journal Articles

Clofarabine Combinations in Adults with Refractory/Relapsed Acute Lymphoblastic Leukemia (ALL): A GRAALL Report

Arnaud Pigneux, MD, PhD, Mathieu Sauvezie, Norbert Vey, MD, Emmanuel Raffoux, MD, PhD, Ambroise Marcais, MD, Françoise Huguet, MD, Philippe Rousselot, MD, PhD, Jean Pierre Marolleau, MD, Stéphane Leprêtre, MD, Pascal Turlure, Patrice Chevallier, MD, Mathilde Hunault, MD, PhD, Caroline Bonmati, MD, Thomas Cluzeau, Thibaut Leguay, MD, Norbert Ifrah, Herve Dombret
Journal: Blood
Blood (2011) 118 (21): 2586.
https://doi.org/10.1182/blood.V118.21.2586.2586
Published: 2011
Journal Articles

Allogeneic Hematopoietic Peripheral Blood Stem-Cell Transplantation From HLA-Identical Siblings Versus Allelic-Matched Unrelated Donors (10/10 high resolution) in Patients with Acute Myeloid Leukemia and Myelodyplasic Syndrome After Reduced Intensity Conditioning,

Marie Robin, Raphael Porcher, Lionel Ades, Emmanuel Raffoux, MD, PhD, Nicolas Boissel, Jérome Larghero, Chantal Himberlin, Claude Gardin, MD, Alain Delmer, MD, Pierre Fenaux, MD, PhD, Hervé Dombret, Gérard Socié, Régis Peffault de Latour
Journal: Blood
Blood (2011) 118 (21): 4132.
https://doi.org/10.1182/blood.V118.21.4132.4132
Published: 2011
Journal Articles

Nelarabine-Based Salvage Therapy in Adult Patients with T-Cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (T-ALL/LL) Relapsing After Allogeneic Stem Cell Transplantation: A French Experience on Behalf of the Group for Research in Adult Lymphoblastic Leukemia (GRAAL),

Edouard Forcade, MD, Thibaut Leguay, MD, Norbert Vey, MD, Andre Baruchel, Jacques Delaunay, Marie Robin, Gérard Socié, Hervé Dombret, Emmanuel Raffoux, MD, PhD, Régis Peffault de Latour
Journal: Blood
Blood (2011) 118 (21): 4095.
https://doi.org/10.1182/blood.V118.21.4095.4095
Published: 2011
Journal Articles

Gene Mutations and Minimal Residual Disease (MRD) As Predictors of Remission Duration in Adults with Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) Treated with High-Dose Cytarabine (HDAC) - First Results of the Prospective French Intergroup CBF-2006 Trial

Eric Jourdan, Nicolas Boissel, Odile Blanchet, Aline Renneville, Christian Recher, MD, PhD, Emmanuel Raffoux, MD, PhD, Pascale Cornillet-Lefebvre, Jean-Michel Cayuela, Jacques Delaunay, Arnaud Pigneux, MD, PhD, Eric Delabesse, Claude-Eric Bulabois, Céline Berthon, Cécile Pautas, Norbert Vey, MD, Bruno Lioure, Xavier Thomas, Nathalie Contentin, Edouard Randriamalala, Nathalie Fegueux, Marie-Christine Béné, Julie Lejeune, Philippe Guardiola, Claude Preudhomme, Norbert Ifrah, Hervé Dombret
Journal: Blood
Blood (2011) 118 (21): 410.
https://doi.org/10.1182/blood.V118.21.410.410
Published: 2011
Journal Articles

Fractionated Doses of Gemtuzumab Ozogamicin (GO) Combined to Standard Chemotherapy (CT) Improve Event-Free and Overall Survival in Newly-Diagnosed De Novo AML Patients Aged 50–70 Years Old: A Prospective Randomized Phase 3 Trial From the Acute Leukemia French Association (ALFA)

Sylvie Castaigne, Cécile Pautas, Christine Terre, Emmanuel Raffoux, MD, PhD, Dominique Bordessoule, Jean-Noel Bastie, MD, PhD, Ollivier Legrand, Xavier Thomas, MD, PhD, Pascal Turlure, Oumedaly Reman, Thierry De Revel, Lauris Gastaud, Claude Gardin, MD, Laurent Sutton, Jean Pierre Marolleau, Stephane De Botton, Olivier Hermine, Isabelle Plantier, Maud Janvier, Brigitte Dupriez, Marc Simon, Noemie De Gunzburg, Stephanie Foucault-Haiat, Nathalie Contentin, Celine Berthon, Pierre Fenaux, MD, PhD, Estelle Henry, Philippe Rousselot, MD, PhD, Claude Preudhomme, Sylvie Chevret, Hervé Dombret
Journal: Blood
Blood (2011) 118 (21): 6.
https://doi.org/10.1182/blood.V118.21.6.6
Published: 2011
Journal Articles

Low-Dose Clofarabine Has Significant Activity in High-Risk Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia Post-MDS (sAML) After Azacitidine (AZA) Failure: Interim Results of the GFM Clo08 Dose Escalating Phase I/II Study (NCT0106325)

Thorsten Braun, Emmanuel Raffoux, MD, PhD, Thomas Prebet, MD, PhD, Sabine Brechignac, Aspasia Stamatoullas, Francois Dreyfus, Zehaira Hebibi, Lionel Ades, Norbert Vey, MD, Hervé Dombret, Pierre Fenaux, MD, PhD, Claude Gardin
Journal: Blood
Blood (2011) 118 (21): 609.
https://doi.org/10.1182/blood.V118.21.609.609
Published: 2011
Journal Articles

Trastuzumab (Herceptin®) for Treatment of Refractory/Relapsed HER2 Positive Adult B-ALL: Results of a Phase II GRAALL Study

Patrice Chevallier, MD, Nelly Robillard, Aude Charbonnier, Emmanuel Raffoux, MD, PhD, Sébastien Maury, Sylvain Carras, Cecile Chabrot, Cecile Fohrer, Marc Bernard, Jean-Sebastien Blade, Anne Etienne, MD, Pascaline Talmant, Jacques Delaunay, Thierry Guillaume, Mohamad Mohty, Norbert Ifrah, Herve Dombret
Journal: Blood
Blood (2011) 118 (21): 1525.
https://doi.org/10.1182/blood.V118.21.1525.1525
Published: 2011